Similar Items: Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults
- Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease following Roux en Y Gastric Bypass: Evidence and Perspectives
- Metabolic and Glycemic Effects of Orforglipron, a GLP‐1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta‐Analysis of Randomised Clinical Trials
- Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes
- A Prospective Evaluation of Glucagon Stimulation Test Safety in Adults With Chronic Moderate‐to‐Severe Traumatic Brain Injury
- Comment on ‘A Prospective Evaluation of Glucagon Stimulation Test Safety in Adults With Chronic Moderate‐to‐Severe Traumatic Brain Injury’
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes